Technology Assessments Update from AHRQ
Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 04/03/2013 07:02 AM EDT
The following new items have been posted:
- Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin.
- Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) Testing of Uterine Cervical Cells to Predict Precancer and Cancer.